Oligoprogressive Metastatic Castration Refractory Prostate Cancer clinical trials

Explore recruiting oligoprogressive metastatic castration refractory prostate cancer clinical trials.

Recruiting oligoprogressive metastatic castration refractory prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligoprogressive Metastatic Castration Refractory Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Metastasis-directed therapy in oligoprogressive castration-refractory prostate cancer: a randomized phase 3 trial

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Oligoprogressive Metastatic Castration Refractory Prostate Cancer trials by city

Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Toronto Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Vancouver Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Montreal Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Calgary Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Edmonton Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Ottawa Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Winnipeg Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Quebec City Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Hamilton Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Kitchener Oligoprogressive Metastatic Castration Refractory Prostate Cancer in London Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Halifax Oligoprogressive Metastatic Castration Refractory Prostate Cancer in New York Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Los Angeles Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Chicago Oligoprogressive Metastatic Castration Refractory Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease